Research programme: T cell receptor therapeutics - T Therapeutics
Latest Information Update: 10 Dec 2023
At a glance
- Originator T-Therapeutics
- Class Anti-inflammatories; Antineoplastics; Gene therapies; Immunotherapies; T lymphocyte cell therapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Autoimmune disorders; Inflammation; Solid tumours